Drugs / [123I]ß CIT
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00129675 | Feb 2003 → May 2009 | parkinsonian disorder | Institute for Neurodegenerative Disorders | Completed | No outcome recorded |
| Phase 2 | NCT00117819 | Mar 2001 → Jan 2013 | parkinsonian disorder | Institute for Neurodegenerative Disorders | Completed | No outcome recorded |
| Phase 2 | NCT00132626 | Sep 1992 → Aug 2005 | Parkinson disease | Institute for Neurodegenerative Disorders | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [123I]ß-CIT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00132626 ↗ |
| Route | Other | “participants are injected with \[123I\]ß CIT” NCT00117819 ↗ |